Shionogi & Co., Ltd. (4507) Press Release
Consolidated Financial Results for the First Quarter of Fiscal Year 2026 (IFRS)
Earlier from Shionogi &
- Shionogi Recognizes the Four-Year Anniversary of RADICAVA ORS® (edaravone) for Treatment of ALS
- Shionogi Announces U.S. Availability of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure*
- Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
- Kirin Group and Blackmores to Launch New Cognizin® Cognitive Support Supplements in Australia and New Zealand